about
Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse modelInfluence of the estrous cycle on clock gene expression in reproductive tissues: effects of fluctuating ovarian steroid hormone levelsGastrin-releasing peptide modulates fast delayed rectifier potassium current in Per1-expressing SCN neurons.Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.Vasoactive intestinal peptide produces long-lasting changes in neural activity in the suprachiasmatic nucleus.The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.Fast delayed rectifier potassium current: critical for input and output of the circadian system.Age-related decline in circadian output.The Circadian Clock Gene Period1 Connects the Molecular Clock to Neural Activity in the Suprachiasmatic Nucleus.Circadian rhythms in the CNS and peripheral clock disorders: the circadian clock and hyperlipidemia.Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviourCircadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid.Effects of vasoactive intestinal peptide genotype on circadian gene expression in the suprachiasmatic nucleus and peripheral organs.Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver.Time-dependent inhibitory effect of lipopolysaccharide injection on Per1 and Per2 gene expression in the mouse heart and liver.The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus.Daily injection of insulin attenuated impairment of liver circadian clock oscillation in the streptozotocin-treated diabetic mouse.Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liver.The dorsomedial hypothalamic nucleus is not necessary for food-anticipatory circadian rhythms of behavior, temperature or clock gene expression in mice.Circadian rhythm disruption in a mouse model of Rett syndrome circadian disruption in RTT.Circadian dysfunction in a mouse model of Parkinson's disease.Clock mutation facilitates accumulation of cholesterol in the liver of mice fed a cholesterol and/or cholic acid diet.Short circuiting the circadian system with a new generation of precision tools.Constant light housing during nursing causes human DSPS (delayed sleep phase syndrome) behaviour in Clock-mutant mice.Effects of medial hypothalamic lesions on feeding-induced entrainment of locomotor activity and liver Per2 expression in Per2::luc mice.PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.In vivo monitoring of peripheral circadian clocks in the mouse.Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet.Optimization of dosing schedule of daily inhalant dexamethasone to minimize phase shifting of clock gene expression rhythm in the lungs of the asthma mouse model.Multifactorial regulation of daily rhythms in expression of the metabolically responsive gene spot14 in the mouse liver.
P50
Q28384426-EDE17D13-FFF5-40E2-8AFA-AD8A104F12ACQ30433104-6C3ACC25-40C6-4317-9B12-6100173FB358Q30469041-5BA9B8A8-15B8-4F68-8F10-7C340972D8CEQ30623834-81A088E0-1C4C-4D85-ACC1-C345A6476EABQ33816631-8A740272-A9C0-41A5-BC85-B1CF3A8D0C57Q34921682-C5B83372-2BB1-4F09-B568-B8C6E56A5BFBQ35132252-CBC255A9-8A8A-45BD-A6EF-6EAF4C3770C6Q35163333-1A36ED61-68E6-46DE-9DD3-D107FBF63630Q36455066-D4061FF5-A355-4771-8491-123DC3A336F0Q36735283-ED16E3C4-AE33-45D9-A577-009E519452CCQ37225400-70E65CB4-2D81-49E7-81C8-3D56A74D80D9Q37476957-2F3A2B8D-7448-4E30-9FE4-77FEA8A1A704Q37616720-F5B862C7-54F1-419F-818F-E142FDF7A682Q38336811-DAB5682C-27CE-42B5-BF06-3D75E56DEE50Q43108527-81CECE50-F42A-4A84-A764-0166079BCAD7Q43151634-6DCEB46D-BF11-46A7-8ADE-DAD080B0B1F9Q45013681-C6F1F3B3-4656-4587-A071-CE34DA84B572Q45016987-7E5120F3-1B2A-49B2-A03A-6649BC4D3FC0Q45972908-96A9CFB6-514D-442A-9891-87EA4508DA60Q46514245-18DBAB6F-18DD-4CE8-B6B0-A19DAF4939B6Q46527998-B4572F8D-C36F-4DDF-90C6-FA63885B09F6Q46923059-069BC920-2747-4421-9479-767A5A5A00A6Q47990095-F05D0417-92C3-48D6-BE77-343FDEF1898AQ48196591-746FB6EC-3DB7-4155-9E5C-4EB3BCF7B7FCQ48344668-082B2DB9-3D8B-4661-8FCF-B6B8B11E1B06Q48471093-28854A9C-EAD8-4982-8B57-3CF70791CE02Q48518211-1A43C9CD-A1D9-409C-854A-6C300B55281DQ50949153-51DD3EA0-6C67-464A-A898-DC4DF2A2989DQ51030529-87AEEC0C-5172-4D38-85B2-B232FE2F5BCAQ51466849-35DD0BFD-706E-4AEF-9A11-02A34CE22F6B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Takashi Kudo
@ast
Takashi Kudo
@en
Takashi Kudo
@es
Takashi Kudo
@nl
Takashi Kudo
@sl
type
label
Takashi Kudo
@ast
Takashi Kudo
@en
Takashi Kudo
@es
Takashi Kudo
@nl
Takashi Kudo
@sl
prefLabel
Takashi Kudo
@ast
Takashi Kudo
@en
Takashi Kudo
@es
Takashi Kudo
@nl
Takashi Kudo
@sl
P1053
K-2491-2016
P106
P21
P31
P3829
P496
0000-0002-9003-0099
P569
2000-01-01T00:00:00Z